Clinical outcomes for Medicare recipients with early-onset breast cancer: An analysis of the National Inpatient Sample.

e23355 Background: Despite recent global decreases in overall cancer incidence, the incidence of early-onset breast cancer (EOBC) is steadily increasing globally. Limited data is available on the comorbid correlations for this unfortunately expanding population. We sought to examine the national inpatient sample database to describe in-hospital outcomes among Medicare recipients with EOBC. Methods: Data were extracted from the National Inpatient Sample (NIS) Database for 2019 and 2020. The NIS was searched for hospitalizations of adult patients with EOBC, defined as all-cause breast cancer in patients 50 years old or younger. We then examined the outcomes of patients who were noted to be active Medicare recipients. Multivariate logistic was used to adjust for confounders. The primary outcome was inpatient mortality and secondary outcomes were annotated accordingly. SPSS software was used for statistical analysis, and all results were powered to p < 0.001. Results: This study included 10,764 patients with EOBC, of which 997 (9.26%) were Medicare users. Multivariate regression showed that Medicare patients with EOBC had higher inpatient mortality (OR 1.104, CI 1.070-1.139, p < 0.001). On secondary analysis, Medicare patients with EOBC were more likely to have systemic lupus erythematosus (OR 1.254, CI 1.118-1.407), anemia (OR 1.128, CI 1.115-1.141), thrombocytopenia (OR 1.143, CI 1.114-1.173), hypertension (OR 1.385, CI 1.301-1.475), chronic kidney disease (OR 1.473, CI 1.358-1.598), acute renal failure (OR 1.159, CI 1.126-1.192), pancreatitis (OR 1.092, CI 1.018-1.172), pericarditis (OR 1.108, CI 1.060-1.157), intracranial hemorrhage (OR 1.288, CI 1.088-1.373), severe liver disease (OR 1.137, CI 1.119-1.155), diabetes mellitus (OR 1.267, CI 1.128-1.423), peptic ulcer disease (OR 1.155, CI 1.074-1.242), obstructive sleep apnea (OR 1.200, CI 1.140-1.263), all-cause arrhythmias (OR 1.153, CI 1.103-1.206), all-cause shock (OR 1.112, CI 1.041-1.188), all-cause heart block (OR 1.294, CI 1.103-1.519), all-cause sepsis (OR 1.134, CI 1.115-1.154), all-cause coagulopathy (OR 1.144, CI 1.102-1.188), all-cause heart failure (OR 1.254, CI 1.191-1.321), all-cause stroke (OR 1.245, CI 1.176-1.318), and all-cause myocardial infarction (OR 1.299, CI 1.174-1.437). Conclusions: In this nationally representative, population‐based retrospective cohort study, Medicare recipients with EOBC were associated with higher mortality and worse outcomes.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Oncology
Published
2025-05-28
DOI
https://doi.org/10.1200/jco.2025.43.16_suppl.e23355
Primary Topic
Global Cancer Incidence and Screening
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Clinical outcomes for Medicare recipients with early-onset breast cancer: An analysis of the National Inpatient Sample.

Mahija Cheekati, Danielle Thor, Tony Elias, Vineet Polineni et al.
Journal of Clinical Oncology
Global Cancer Incidence and Screening
article

Clinical outcomes for Medicare recipients with early-onset breast cancer: An analysis of the National Inpatient Sample.

Mahija Cheekati, Danielle Thor, Tony Elias, Vineet Polineni, Ben Brik
article en

Abstract

e23355 Background: Despite recent global decreases in overall cancer incidence, the incidence of early-onset breast cancer (EOBC) is steadily increasing globally. Limited data is available on the comorbid correlations for this unfortunately expanding population. We sought to examine the national inpatient sample database to describe in-hospital outcomes among Medicare recipients with EOBC. Methods: Data were extracted from the National Inpatient Sample (NIS) Database for 2019 and 2020. The NIS was searched for hospitalizations of adult patients with EOBC, defined as all-cause breast cancer in patients 50 years old or younger. We then examined the outcomes of patients who were noted to be active Medicare recipients. Multivariate logistic was used to adjust for confounders. The primary outcome was inpatient mortality and secondary outcomes were annotated accordingly. SPSS software was used for statistical analysis, and all results were powered to p < 0.001. Results: This study included 10,764 patients with EOBC, of which 997 (9.26%) were Medicare users. Multivariate regression showed that Medicare patients with EOBC had higher inpatient mortality (OR 1.104, CI 1.070-1.139, p < 0.001). On secondary analysis, Medicare patients with EOBC were more likely to have systemic lupus erythematosus (OR 1.254, CI 1.118-1.407), anemia (OR 1.128, CI 1.115-1.141), thrombocytopenia (OR 1.143, CI 1.114-1.173), hypertension (OR 1.385, CI 1.301-1.475), chronic kidney disease (OR 1.473, CI 1.358-1.598), acute renal failure (OR 1.159, CI 1.126-1.192), pancreatitis (OR 1.092, CI 1.018-1.172), pericarditis (OR 1.108, CI 1.060-1.157), intracranial hemorrhage (OR 1.288, CI 1.088-1.373), severe liver disease (OR 1.137, CI 1.119-1.155), diabetes mellitus (OR 1.267, CI 1.128-1.423), peptic ulcer disease (OR 1.155, CI 1.074-1.242), obstructive sleep apnea (OR 1.200, CI 1.140-1.263), all-cause arrhythmias (OR 1.153, CI 1.103-1.206), all-cause shock (OR 1.112, CI 1.041-1.188), all-cause heart block (OR 1.294, CI 1.103-1.519), all-cause sepsis (OR 1.134, CI 1.115-1.154), all-cause coagulopathy (OR 1.144, CI 1.102-1.188), all-cause heart failure (OR 1.254, CI 1.191-1.321), all-cause stroke (OR 1.245, CI 1.176-1.318), and all-cause myocardial infarction (OR 1.299, CI 1.174-1.437). Conclusions: In this nationally representative, population‐based retrospective cohort study, Medicare recipients with EOBC were associated with higher mortality and worse outcomes.

Journal of Clinical OncologyVol. 43(16_suppl)
Thomas Jefferson University Hospital (US), Morristown Medical Center (US), Rowan University (US)
Openalex Percentile: Top 82%
Global Cancer Incidence and Screening
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.